Compare CRDL & VIOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRDL | VIOT |
|---|---|---|
| Founded | 2017 | 2014 |
| Country | Canada | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Consumer Electronics/Appliances |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 97.3M | 87.0M |
| IPO Year | 2017 | 2018 |
| Metric | CRDL | VIOT |
|---|---|---|
| Price | $1.03 | $1.38 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $9.00 | N/A |
| AVG Volume (30 Days) | ★ 365.5K | 278.8K |
| Earning Date | 05-13-2026 | 03-25-2026 |
| Dividend Yield | N/A | ★ 5.84% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $42.19 |
| Revenue Next Year | N/A | $0.96 |
| P/E Ratio | ★ N/A | $3.56 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.77 | $1.18 |
| 52 Week High | $1.59 | $4.33 |
| Indicator | CRDL | VIOT |
|---|---|---|
| Relative Strength Index (RSI) | 51.67 | 48.14 |
| Support Level | $0.95 | $1.22 |
| Resistance Level | $1.09 | $1.50 |
| Average True Range (ATR) | 0.06 | 0.08 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 63.00 | 40.68 |
Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's main product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.
Viomi Technology Co Ltd, along with its subsidiaries, specializes in the development and sale of Internet-of-Things-enabled smart home products, particularly focusing on home water solutions. The company markets its products in China and generates the majority of its revenue through the sale of smart water purification systems and other connected home devices designed to improve convenience and automation in residential settings. Its product offerings include water purification products, water heaters, smart water kettles, electric kettles, water filters, range hoods, gas stoves, and other small appliances.